Chemoinformaics analysis of 4-Methoxymethoxy-hex-1-ene
Molecular Weight | 144.214 | nRot | 6 |
Heavy Atom Molecular Weight | 128.086 | nRig | 1 |
Exact Molecular Weight | 144.115 | nRing | 0 |
Solubility: LogS | -1.59 | nHRing | 0 |
Solubility: LogP | 1.791 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.6327 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.419 |
Synth | 3.308 |
Natural Product Likeliness | 1.239 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.174 |
MDCK | 0.0000308 |
BBB | 0.962 |
PPB | 0.338098 |
VDSS | 0.924 |
FU | 0.602938 |
CYP1A2-inh | 0.12 |
CYP1A2-sub | 0.907 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.882 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.233 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.747 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.34 |
CL | 9.821 |
T12 | 0.554 |
hERG | 0.012 |
Ames | 0.023 |
ROA | 0.021 |
SkinSen | 0.539 |
Carcinogencity | 0.507 |
EI | 0.992 |
Respiratory | 0.086 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.938148 |